Caxton Associates (New York)’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $413K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $227K | Sell |
|
|||||
|
2022
Q1 | $1.03M | Buy |
|
|||||
|
2021
Q4 | $275K | Hold |
|
|||||
|
2021
Q3 | $215K | Sell |
|
|||||
|
2021
Q2 | $247K | Buy |
|
|||||
|
2021
Q1 | $113K | Hold |
|
|||||
|
2020
Q4 | $82K | Buy |
|
|||||
|
2020
Q3 | $34K | Sell |
|
|||||
|
2020
Q2 | $488K | Buy |
|
|||||
|
2020
Q1 | $100K | Buy |
|